Skip to main content

Patient onboarding: The impact of GenAI on oncology care

Introduction

Generative AI (GenAI) can play a crucial role in transforming health care. This technology makes it possible to streamline both clinical and administrative processes, while also enabling faster and more accurate analysis of large datasets, contributing to quicker and more precise diagnoses. By investing in GenAI, health care providers can deliver increasingly personalized care tailored to each patient’s needs. For the Champalimaud Foundation, investing in technology is essential, especially when it comes to processing complex patient data that often comes from multiple sources and contains vital information needed to deliver the highest-quality care.

The situation

How can a meaningful impact be achieved from the patient’s very first contact?

The Champalimaud Foundation is committed to advancing cutting-edge biomedical research and delivering high-quality clinical care. Its commitment to offering a more humanized and efficient patient experience aligns with its vision of leading innovation in oncology care and other health areas. As a secondary health care provider, and given the complexity of the conditions it treats, its processes and operations rely on contributions from many individuals, both clinical and administrative. Many of its patients are referred by other health care entities, often seeking a second opinion or specialized advice, which adds further complexity to patient onboarding. This makes patient onboarding one of the foundation’s most critical focus areas.

Within this operational context and given its distinct care model and approach to patient engagement, it was important to strike the right balance between technology, health care professionals, and patients. GenAI offered the opportunity to streamline administrative and clinical workflows, automate repetitive tasks, and help enable faster and more accurate analysis of large volumes of clinical data. From the standpoint of patient outcomes, the potential was equally significant: enabling quicker and more precise diagnoses, accelerating the understanding of patient histories, and supporting continuous, proactive follow-up tailored to each patient’s specific needs.

GenAI offered the opportunity to streamline administrative and clinical workflows, automate repetitive tasks, and help enable faster and more accurate analysis of large volumes of clinical data

The solution

Looking into the future

This collaboration between the Champalimaud Foundation and Deloitte Portugal’s GenAI specialists aimed to improve how patient history is identified and analyzed, helping to enable more informed decisions about the Foundation’s next steps in patient care.

From the outset, the potential of this GenAI-based solution was clear: to transform how the Foundation receives, supports, and treats its patients by integrating innovative tools that enhance the patient experience, personalize care, and improve clinical workflows.

Deloitte approached this challenge through its Health Care Specialty Center. From the beginning, Deloitte recognized that the success of the project would depend on having the right people in place. This is why the project brought together professionals with deep functional and clinical knowledge in the health care sector (doctors, nurses, and biomedical engineers, among others), who worked closely with specialists from Deloitte’s GenAI Hub and collaborated directly with the clinical lead at the Champalimaud Foundation. This connection was essential to understanding real-world challenges and to help ensure the solution aligned with clinical needs.

Technology as the main driver

The implemented solution, GenAI Streamlining Patient Onboarding Process, enabled the Foundation to streamline processes and the overall patient journey, without compromising the quality of care.

Lung cancer was chosen as the initial use case, and the requirements needed to fine tune the AI model were defined based on that. The solution was developed to accelerate the review of a patient’s clinical history prior to their admission to the Champalimaud Foundation, increasing efficiency during intake and enabling physicians to devote more attention to the patient. 

Ultimately, this contributed to a more human-centered experience. The project demonstrated how technology, when combined with human knowledge, can fundamentally improve the way complex health care challenges are addressed.

The impact

A collaboration that creates impact for everyone

The implementation of the solution led to significant improvements in patient care, including higher patient retention and better-quality consultations. It also optimized clinicians’ time by reducing the effort required to process information and reinforcing their focus on evaluation, validation, and clinical follow-up, resulting in a more efficient and patient-centered service.

Digital transformation today represents not just an opportunity, but a necessity in responding to the challenges faced by the health care sector. Advanced technologies have the potential to increase productivity and efficiency, reduce costs, and address shortages of human and financial resources. But their impact goes far beyond that. When adopted by health care organizations, these technologies have the potential to improve quality of life and enhance each patient’s journey by strengthening prevention efforts, accelerating access to care, enabling faster and more accurate diagnoses, and supporting more personalized treatments. Collaboration can shape the future of health care systems.

“Thinking about our vision for the future, the solution we implemented allowed us to create working and co‑development methodologies between parties that do not always speak the same language or share the same sense of usefulness or urgency.”

—Pedro Garcia da Silva, CIO, Fundação Champalimaud

Explore our capabilities

Delivered in alliance with

Deloitte awards and recognition

Did you find this useful?

Thanks for your feedback